Company dossier
TELEFLEX INC
Company overview
Teleflex Inc. (CIK 96943) sits in SIC 3841 beneath the broader medical instruments industry, offering specialty procedural solutions such as surgical devices, anesthesia products, and vascular access systems that are essential to hospitals, surgical centers, dialysis providers, and ambulatory care networks; the company blends proprietary engineering, regulatory-compliant manufacturing, and clinical partnerships to deliver capital equipment and disposable offerings for critical care, vascular, and endoscopic procedures while servicing both acute care and specialized outpatient segments. Focused on innovation supporting clinicians in high-stakes settings, Teleflex markets solutions spanning from image-guided procedures to patient monitoring accessories, often bundling consumables with service programs to streamline procurement for healthcare systems. Material risks include supply chain disruptions, reimbursement pressure, and the need to secure FDA clearances and CE marks as products evolve, while also managing cybersecurity, compliance, and pricing scrutiny within its global footprint; the latest filing details are currently unavailable. View live SEC filings for TFX on Earnings Feed.
Source: Earnings Feed research · last updated 11/24/2025
Last trade
$114.70
−$17.21 (−13.05%)Ticker
Prev close
Range (29d)
Updated
Recent filings
- TELEFLEX INC32.1 KB
TELEFLEX INC 10-Q
- TELEFLEX INC31.8 KB
TELEFLEX INC 10-Q
- TELEFLEX INC31.6 KB
TELEFLEX INC 10-Q
- TELEFLEX INC177.0 KB
TELEFLEX INC 10-K
- TELEFLEX INC176.7 KB
TELEFLEX INC 8-K
- TELEFLEX INC37.1 KB
TELEFLEX INC 10-Q
- TELEFLEX INC26.6 KB
TELEFLEX INC 10-Q
Ticker roster
- Exchange hub ↗
TFX
NYSE
Addresses
business
550 E SWEDESFORD RD SUITE 400
WAYNE, PA, 19087
mailing
550 E SWEDESFORD RD SUITE 400
WAYNE, PA, 19087